Effect of Helicobacter pylori Eradication on Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasm

被引:103
作者
Bae, Suh Eun [1 ]
Jung, Hwoon-Yong [1 ]
Kang, June [2 ]
Park, Young Soo [2 ]
Baek, Seunghee [3 ]
Jung, Ji-Hoon [1 ]
Choi, Ji Young [1 ]
Kim, Mi-Young [1 ]
Ahn, Ji Yong [1 ]
Choi, Kwi-Sook [1 ]
Kim, Do Hoon [1 ]
Lee, Jeong Hoon [1 ]
Choi, Kee Don [1 ]
Song, Ho June [1 ]
Lee, Gin Hyug [1 ]
Kim, Jin-Ho [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Asan Digest Dis Res Inst, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol,Asan Digest Dis Res Inst, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol,Asan Digest Dis Res Inst, Seoul 138736, South Korea
关键词
RANDOMIZED CONTROLLED-TRIAL; MONGOLIAN GERBILS; MUCOSAL RESECTION; VIENNA CLASSIFICATION; CANCER INCIDENCE; LUNG-CANCER; CARCINOGENESIS; INFECTION; CARCINOMA; METAANALYSIS;
D O I
10.1038/ajg.2013.404
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Although many epidemiologic studies have shown that Helicobacter pylori (H. pylori) eradication has prophylactic effects on gastric cancer, their results are less clear in high-risk populations. We conducted this study to examine whether H. pylori eradication would affect the occurrence of metachronous gastric cancer after endoscopic resection in patients with early gastric cancer. METHODS: We retrospectively analyzed 2,089 adults who underwent endoscopic resection of gastric low-grade neoplasia, high-grade neoplasia, or differentiated invasive neoplasia from 2004 to 2008 at Asan Medical Center. Of these, a total of 1,007 patients with early gastric cancer were enrolled in this study. We evaluated the demographic data, the pathology, and the incidence of metachronous recurrence by dividing them into three groups: those without active H. pylori infection (Hp negative group, n = 340), those who successfully underwent H. pylori eradication (eradicated group, n = 485), and those who failed or did not undergo H. pylori eradication (noneradicated group, n = 182). RESULTS: Metachronous recurrence was diagnosed in 75 patients, including 17 in the Hp, 34 in the eradicated, and 24 in the noneradicated groups. Median time to metachronous recurrence was 18 months (range, 7-75 months). The incidence of metachronous gastric cancer was 10.9 cases per 1,000 person-years in the Hp negative group, 14.7 cases per 1,000 person-years in the eradicated group, and 29.7 cases per 1,000 person-years in the noneradicated group. The hazard ratios in the noneradicated group compared with the Hp negative and eradicated groups were 2.5 (P < 0.01) and 1.9 (P = 0.02), respectively. H. pylori eradication reduced metachronous recurrence of gastric neoplasm, which was also shown in the secondary analysis of 1,487 patients with low-grade neoplasia and early gastric cancer. CONCLUSIONS: Successful H. pylori eradication may reduce the occurrence of metachronous gastric cancer after endoscopic resection in patients with early gastric cancer.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
[2]   Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification [J].
Cho, S. -J. ;
Choi, I. J. ;
Kim, C. G. ;
Lee, J. Y. ;
Kook, M. -C. ;
Park, S. ;
Ryu, K. W. ;
Lee, J. H. ;
Kim, Y. -W. .
ENDOSCOPY, 2011, 43 (06) :465-471
[3]   EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes [J].
Choi, Kwi-Sook ;
Jung, Hwoon-Yong ;
Choi, Kee Don ;
Lee, Gin Hyug ;
Song, Ho June ;
Kim, Do Hoon ;
Lee, Jeong Hoon ;
Kim, Mi-Young ;
Kim, Byung Sik ;
Oh, Sung Tae ;
Yook, Jeong Hwan ;
Jang, Se Jin ;
Yun, Sung-Cheol ;
Kim, Seon Ok ;
Kim, Jin-Ho .
GASTROINTESTINAL ENDOSCOPY, 2011, 73 (05) :942-948
[4]   Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection as Treatments for Early Gastrointestinal Cancers in Western Countries [J].
Coda, Sergio ;
Lee, Sun-Young ;
Gotoda, Takuji .
GUT AND LIVER, 2007, 1 (01) :12-21
[5]  
CORREA P, 1988, CANCER RES, V48, P3554
[6]   Four-year trends in Helicobacter pylori IgG serology following successful eradication [J].
Cutler, AF ;
Prasad, VM ;
Santogade, P .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01) :18-20
[7]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[8]  
Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x
[9]   Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan [J].
Etoh, T ;
Katai, H ;
Fukagawa, T ;
Sano, T ;
Oda, I ;
Gotoda, T ;
Yoshimura, K ;
Sasako, M .
GASTROINTESTINAL ENDOSCOPY, 2005, 62 (06) :868-871
[10]   Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer:: an open-label, randomised controlled trial [J].
Fukase, Kazutoshi ;
Kato, Mototsugu ;
Kikuchi, Shogo ;
Inoue, Kazuhiko ;
Uemura, Naomi ;
Okamoto, Shiro ;
Terao, Shuichi ;
Amagai, Kenji ;
Hayashi, Shunji ;
Asaka, Masahiro .
LANCET, 2008, 372 (9636) :392-397